Whether to treat low testosterone in men with obesity will be the topic of “ Low Testosterone in Obesity: Should We Treat or Not?” a debate session at ENDO 2026 that is sure to be somewhat vigorous as two experts in the field take sides in a session moderated by Endocrine Society Past-President Stephen Hammes, MD, PhD. The question might seem simple enough: Should we treat low testosterone in men with obesity?
Yet the questions only accrue from here. The field remains divided not only on whether to treat it but also on how — and even on what to call it.
This standoff is why an upcoming ENDO session in Chicago promises to be one of the meeting’s most spirited exchanges. On Sunday, June 14, two leading experts in andrology will face off in a structured debate, moderated by a physician who says he is “fortunate to know them personally” and anticipates a lively morning.
“They are both extremely intelligent and know their field well,” says moderator and Endocrine Society Past-President Stephen Hammes, MD, PhD.
Endocrine News published a clinical update in Research Highlights on 10 Jun 2026.
The item focuses on To T or Not To T: Should We Treat Low Testosterone in Men with Obesity?.
Review the original article for the full source wording and details.